Norovirus vaccine proves effective in human tests, researchers say

Share this article:

Clinical tests indicate that a potential norovirus vaccine is highly effective in reducing symptoms of the infection, researchers have announced.

The study involved 98 people who drank water dosed with norovirus, 50 of whom received the injected vaccine, according to the Infectious Diseases Society of America. The researchers involved, led by David I. Bernstein, M.D., M.A., presented their findings at last week's IDWeek 2013 conference.

Among those who received the vaccine, 26 people were infected, the researchers said. In the other group, 29 people were infected. However, only 10 people who were vaccinated developed mild, moderate or severe vomiting and/or diarrhea, compared with 20 people in the placebo group. This means the vaccine achieved a 52% reduction in symptoms.

People in nursing homes are at high risk for norovirus and could benefit from the vaccine if further testing confirms its effectiveness, stated Bernstein, who is affiliated with Cincinnati Children's Hospital Medical Center and the University of Cincinnati.

Long-term care facilities bore the brunt of a norovirus outbreak that began a year ago, according to the Centers for Disease Control and Prevention.

Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.